CRISPR: From Discovery To Clinic And Charting A Path Forward

Get the Full StoryNo doubt 2025 will usher in many more advances in CRISPR therapies, thanks to the FDA s new Platform Technology Designation Program, which will allow innovators to have an easier path to market.

Share: